SARAH SHAPIRO: Open Payments
NPI 1841984598 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 33 payments from 22 companies in 2025. Trend: 2023 $346 · 2024 $1,071 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Genentech USA, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| PharmaEssentia USA Corporation | 2 | $46 |
| Incyte Corporation | 2 | $43 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Geron Corporation | 1 | $25 |
Products named: Vanflyta, Venclexta, KISQALI, Enhertu, BESREMI, Nubeqa, ULTOMIRIS, Trodelvy.
Industry payments across GA — which companies pay providers there.
